High-dose intravenous immunoglobulin delays clearance of von Willebrand factor in acquired von Willebrand disease.
D000328:Adult; D001323:Autoantibodies / Q000276:immunology; D001327:Autoimmune Diseases / Q000378:metabolism* / Q000628:therapy; D005260:Female; D006406:Hematoma / Q000209:etiology; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D016756:Immunoglobulins, Intravenous / Q000494:pharmacology* / Q000627:therapeutic use; D008657:Metabolic Clearance Rate; D014842:von Willebrand Diseases / Q000378:metabolism* / Q000628:therapy; D014841:von Willebrand Factor / Q000378:metabolism / Q000493:pharmacokinetics*
D001323:Autoantibodies; D007074:Immunoglobulin G; D016756:Immunoglobulins, Intravenous; D014841:von Willebrand Factor